Inspired by previous studies, our nomogram model is based on the available clinical high performance in predicting the 1-year prognosis of CHD patients combined with AHF, including diabetes, HF history, NYHA ≥ 3, NT-proBNP, Lp-PLA2, and Hcy. This evidence concerns the gene PLA2G7 and hydrops fetalis.